Telehealth Ketamine in Georgia: Access, Laws, and What to Know

Telehealth ketamine treatment is legal in Georgia when a licensed prescriber completes a real-time video evaluation and follows the standards set by the Georgia Composite Medical Board, the state agency that licenses physicians and oversees telehealth practice rules in Georgia. Ketamine is a Schedule III controlled substance, a federal classification for drugs with accepted medical use and moderate potential for abuse or dependence. Because of that classification, Georgia prescribers must also follow the federal Ryan Haight Online Pharmacy Consumer Protection Act, a 2008 law that sets baseline requirements for prescribing controlled substances through telemedicine. This guide explains what Georgia residents need to know before starting telehealth ketamine in Georgia, including licensing rules, provider availability, compounding pharmacy access, and typical costs in 2026.

Is Telehealth Ketamine Legal in Georgia?

Yes. Georgia Senate Bill 60, enacted in 2019, established telehealth practice standards and insurance parity requirements under Georgia Code Title 43 (professional licensing) and Title 33 (insurance). The law allows a provider to establish a valid patient relationship through telehealth and to prescribe medications, including controlled substances, when clinically appropriate. The Georgia Composite Medical Board requires telehealth encounters to meet the same standard of care as in-person visits, meaning providers must conduct an adequate evaluation, document clinical findings, and maintain complete medical records.

Because ketamine is a Schedule III controlled substance under Georgia's Controlled Substances Act (OCGA 16-13-27), prescribers must query Georgia's prescription drug monitoring program before writing a prescription. The PDMP is operated by the Georgia Drugs and Narcotics Agency, the state agency responsible for overseeing controlled substance distribution. Providers must also hold an active Georgia medical license and a DEA registration under the framework described by the DEA Diversion Control Division, which administers the Ryan Haight Act.

Georgia nurse practitioners can prescribe Schedule III medications like ketamine only under a nurse protocol agreement with a delegating physician, so the prescriber on a telehealth visit may be a physician, a nurse practitioner, or in some cases a physician assistant depending on scope-of-practice rules. Patients can confirm a prescriber's license through the Georgia Composite Medical Board or the state nursing board. For a broader look at how these rules compare across states, see our state-by-state telehealth regulations guide.

Provider Availability in Georgia

Provider availability for telehealth ketamine in Georgia is moderate to high. Georgia's population of approximately 10.9 million supports a substantial healthcare market, and the Atlanta metropolitan area, home to more than 6 million residents, serves as a regional medical hub for the Southeast. Most national telehealth ketamine platforms serve Georgia patients, and availability is strongest in metro Atlanta, Savannah, Augusta, Columbus, and Macon.

Telehealth extends access to patients in rural south Georgia and the mountains of north Georgia, where in-person psychiatric specialists can be scarce. Georgia participates in the Interstate Medical Licensure Compact, a streamlined licensing pathway that lets physicians already licensed in a member state obtain a Georgia license more quickly, which helps expand the pool of telehealth ketamine prescribers available to Georgia residents. Our guide to choosing a ketamine provider outlines the credentials and safety practices worth checking.

Compounding Pharmacy Access in Georgia

Compounding pharmacy access is generally good for Georgia patients. The Georgia Board of Pharmacy regulates compounding operations under the Georgia Pharmacy Practice Act, and out-of-state compounding pharmacies must hold a nonresident pharmacy permit before shipping compounded medications into Georgia. The board enforces USP compounding standards, quality benchmarks published by the U.S. Pharmacopeia for sterile and non-sterile compounded drugs, for both in-state and nonresident pharmacies.

Georgia's location in the Southeast typically means two to four business day shipping from major compounding hubs. Georgia does not add restrictions on compounded ketamine beyond standard compounding and controlled substance rules, so pharmacy access is straightforward for patients with a valid prescription. For context on how compounded ketamine differs from the FDA-approved nasal spray, see our comparison of generic ketamine versus Spravato.

Insurance and Cost Considerations in Georgia

Georgia's telehealth parity law (SB 60) requires commercial insurers to cover telehealth visits the same way they cover in-person care, but that requirement applies to the visit format, not to off-label medications. Compounded ketamine for psychiatric indications generally remains outside standard coverage for most private insurance plans. Spravato (esketamine), an FDA-approved nasal spray for treatment-resistant depression, is more likely to be covered when a patient meets diagnostic criteria and a plan approves prior authorization.

Georgia Medicaid, administered through the Department of Community Health, may cover Spravato with prior authorization but does not cover compounded ketamine for mental health conditions, and PeachCare for Kids, Georgia's CHIP program, does not cover compounded ketamine either. Georgia has a relatively large uninsured population, so many residents who could benefit from ketamine therapy face out-of-pocket costs. Monthly costs for telehealth ketamine treatment in Georgia typically range from $150 to $300 for medication and $100 to $250 for consultations, with metro Atlanta pricing sometimes running slightly higher. See our insurance versus cash-pay comparison and our guide to Medicare coverage for ketamine therapy for more detail on what to expect nationally.